Timing and timelines

When does hair loss start on Zepbound?

Often around months 2 to 4. Here’s why women report it far more than men, and what to do while you watch for it.

By Gavin Larsen | Doctor of TCM Diploma · · 7 min read

When does hair loss start on Zepbound: illustration of a bedside lamp and a glowing phone at night.

The short answer

When does hair loss start on Zepbound? When shedding happens, it’s often noticed around months 2 to 4, a few months after appetite first drops. Not everyone on Zepbound sheds, and the timing varies. A dose increase or a switch from another GLP-1 is worth noting too, if it brings a big change in appetite. Women report it far more than men: 7.1% versus 0.5% in the trials behind the label. If it’s a short-term shed, it often gets better over the following months, but Zepbound studies haven’t measured how long it lasts.

In this post
  1. The delay, briefly
  2. Reading the Zepbound label
  3. It isn’t just Zepbound
  4. Why women see it more
  5. If you switched from Wegovy or Ozempic
  6. Shedding in your first few weeks?
  7. The birth control note
  8. What to do this week
  9. Quick answers

When does hair loss start on Zepbound, and why the delay?

Zepbound is tirzepatide, the same drug as Mounjaro, approved for weight loss. Like every GLP-1, it doesn’t make hair fall out the week you start. If it’s telogen effluvium, a trigger like a fast drop in food or weight can push a batch of hairs into rest. They often fall about two to three months later, though people vary.

I explain the full hair cycle in the GLP-1 hair loss timeline, and how Mounjaro’s dose steps fit in when hair loss starts on Mounjaro. Everything there applies to Zepbound. This post focuses on what the Zepbound label tells women in particular.

Reading the Zepbound label

Zepbound’s label is one of the clearest sources we have on GLP-1 hair loss, and it rewards a careful read.

What the label showsThe numberWhat it suggests
Hair loss by doseAbout 5% at 5 mg, 4% at 10 mg, 5% at 15 mg, against 1% on placeboBarely any difference between doses
Hair loss by sex7.1% of women, 0.5% of men (placebo 1.3% and 0%)Women reported it far more
Stopped the drug for hair lossNo one on Zepbound in the trialsTrials miss how upsetting it can be in real life
What it was linked to“Associated with weight reduction”A link to weight loss. The cause isn’t settled

That first row is the interesting one. Hair loss didn’t rise neatly with the dose. That makes a simple “more drug, more damage” story less likely. But it can’t tell us whether the cause is weight loss, eating less, the drug itself or a mix. Compare that with Wegovy’s newer 7.2 mg dose, where hair loss rose from 3.3% at 2.4 mg to 5.8% at 7.2 mg in its trials. There, the higher dose group lost more weight and reported more hair loss, but the trial can’t say which one explains the difference.

Real life looks busier than the trials. A small 2026 survey asked GLP-1 users about their hair. Of those on tirzepatide, 76.7% said they’d noticed shedding (Alharbi and Alkhalifah, Skin Appendage Disorders). People reported it themselves, and the survey found them on social media. So it can’t tell us how common shedding really is. Trials and surveys catch hair changes in different ways, and the true rate is still unknown.

It isn’t just Zepbound

If you’re weighing your options, know this. The gap between women and men shows up across the newest GLP-1s, not just Zepbound. In the trials for Wegovy’s 7.2 mg dose, 8.4% of women reported hair loss. In the trials for Foundayo, the new daily pill, it was 7.0% of women and 0.9% of men. That’s even though the pill takes off less weight on average than Zepbound.

So switching to a pill, or to a different injection, isn’t a reliable way to sidestep a shed. Planning your eating for the early months is a better use of your energy.

Why women see it more

Nobody has proven exactly why the gap is so wide. From what I see in practice, three things stack up for women and rarely for men:

  • Thinner iron reserves. Monthly periods, especially heavy ones in your 40s, drain the iron your follicles lean on. A sudden drop in food lands harder when those reserves were already low.
  • A pattern waiting underneath. Many women carry a tendency toward female pattern thinning that hasn’t shown yet. A shed can pull it into view. One study included in a 2025 review found 91.4% of patients with GLP-1-linked hair loss had a personal history of hair loss.
  • Hormones in motion. Perimenopause and menopause change hair on their own. A weight-loss shed on top looks bigger and feels scarier.

A 7.1% versus 0.5% gap is a reason to plan ahead, and nothing to feel vain about.

If you switched from Wegovy or Ozempic

Illustration of two plain medicine boxes side by side with a gold arrow between them.

A lot of women come to Zepbound from semaglutide. For your hair, a switch counts as a new start. If Zepbound quiets your appetite more than your old medication did, that can be a new trigger. A new wave may follow weeks to months later.

So if you switched in June and started shedding in September, the switch is one of the first things I’d put on the timeline. One Drugs.com reviewer who’d been moved from Wegovy to Zepbound said her doctors simply told her it would get better. That’s often true. It’s also not much of a plan, which is why the steps below exist.

Shedding in your first few weeks?

If you’re two or three weeks in and already losing a lot of hair, it’s very unlikely to be a weight-loss shed from Zepbound. The timing doesn’t fit. That usually means the trigger came earlier.

Lots of things can land 2 to 4 months before a shed. A bad flu or fever. Surgery or giving birth. Stopping or changing birth control. A crash diet before you started the medication. A very stressful stretch, or a new medication. Thyroid changes and low iron can also cause shedding on their own schedule. It’s worth telling your doctor, because “it’s just the Zepbound” might be the wrong answer.

The birth control note women should know

This one isn’t about hair, but it matters to many women starting Zepbound in their 30s and 40s, and it’s easy to miss.

Tirzepatide slows how fast your stomach empties. That can lower how much of a birth control pill your body takes in. The Zepbound label covers this. People on the pill should switch to a non-pill method, or add a barrier method like condoms. That’s for 4 weeks after starting and 4 weeks after each dose increase. Ask your prescriber what fits you.

What to do this week

If you’re early on Zepbound, three conversations with your prescriber will do more than any product.

  1. Ask whether your pace of loss is where they want it. Mention any shedding, and when it started. The dose decision is theirs.
  2. Ask about birth control during dose steps. Especially if you use the pill.
  3. If you switched, ask how to eat through the change. The first weeks on a new GLP-1 are when appetite often drops hardest.
  4. Mention heavy periods. If yours are heavy, it’s worth asking whether checking your iron makes sense.

The full list of labs and the stage-by-stage plan are in the GLP-1 hair loss timeline.

Quick answers

Does Zepbound cause hair loss?

Hair loss is listed on the Zepbound label, which ties it to weight reduction. Fast weight loss and eating less are likely parts of the picture. But studies can’t yet rule out an effect from the drug itself.

Does a higher Zepbound dose mean more hair loss?

Not in the label’s trials. Hair loss was about the same at 5, 10 and 15 mg. That makes a simple dose effect less likely, but it doesn’t settle the cause.

Why do women lose more hair on Zepbound?

Nobody has proven the exact reason. Possible pieces include lower iron stores, a built-in tendency toward pattern thinning and midlife hormone changes. None has been proven to explain the gap.

Is Zepbound hair loss different from Mounjaro hair loss?

No. They’re the same drug, tirzepatide, under two brand names.

Should I switch back to my old medication?

That’s a decision for you and your prescriber. Switching again doesn’t call back hair that’s already resting, and each change can be a new trigger.

Sources

  • Zepbound (tirzepatide) injection, US prescribing information, Eli Lilly.
  • Wegovy (semaglutide) 7.2 mg prescribing information, Novo Nordisk, 2026.
  • Eli Lilly. Medical information: incidence of hair loss with Foundayo (orforglipron), 2026.
  • Alharbi S, Alkhalifah A. Hair shedding among GLP-1 receptor agonist users. Skin Appendage Disorders, 2026.
  • Rojas Lopez et al. Scoping review of GLP-1-associated hair loss. Cureus, 2025.
  • Rebora A. Telogen effluvium: a comprehensive review. Clinical, Cosmetic and Investigational Dermatology, 2019.
  • Drugs.com, Zepbound patient reviews, 2026.

Your next step

Get ready before anything changes.

Not everyone on Zepbound sheds. If you’ve had a big shed before, or thinning runs in your family, it’s worth planning earlier. The free 3-Pattern Shed Check shows where to start, even if you’re not shedding yet. The 8-week plan has a Before You Start path.

Free

The 3-Pattern Shed Check

See which pattern your answers most closely match, or where to begin if you’re not shedding yet.

Take the free 3-Pattern Shed Check

8 weeks

The No-Trade-Off Hair Plan

Before, during or after weight loss, with or without a GLP-1.

Explore the 8-week plan
Gavin Larsen

Gavin Larsen | Doctor of TCM Diploma

12+ years in practice.

About Gavin

Gavin Larsen holds a Doctor of TCM Diploma. The “Dr.” refers to that TCM diploma, not a medical degree. This is education, not a diagnosis. Don’t start, stop or change any medication without your prescriber.